SA
UTMD icon

Sanctuary Advisors’s Utah Medical Products UTMD Stock Holding History

Sanctuary Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225K Buy
+3,628
New +$229K ﹤0.01% 2288
2025
Q4 		– Sell
-3,706
Closed -$233K – 2576
2025
Q3 		$233K Sell
3,706
-794
-18% -$47K ﹤0.01% 2168
2025
Q2 		$256K Sell
4,500
-3,060
-40% -$166K ﹤0.01% 2010
2025
Q1 		$424K Buy
7,560
+599
+9% +$35.9K ﹤0.01% 1612
2024
Q4 		$426K Buy
6,961
+963
+16% +$62.3K ﹤0.01% 1788
2024
Q3 		$392K Sell
5,998
-268
-4% -$18.2K ﹤0.01% 1849
2024
Q2 		$413K Buy
+6,266
New +$427K ﹤0.01% 1761

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanctuary Advisors's UTMD Position: Q1 2026 in Review

Sanctuary Advisors opened a new position in Utah Medical Products (UTMD) in Q1 2026: 3,628 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #2288 among its holdings. This is a return to the name: Sanctuary Advisors previously reported a position in UTMD as recently as Q3 2025.

Sanctuary Advisors first reported a position in UTMD in Q2 2024 and has held it in 7 quarters since. The position peaked at $426K in Q4 2024. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Sanctuary Advisors held 3,628 shares of Utah Medical Products worth $225K as of Q1 2026.
  • Utah Medical Products was a new Sanctuary Advisors position in Q1 2026.
  • Utah Medical Products made up ﹤0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #2288 holding.
  • Sanctuary Advisors first reported a position in Utah Medical Products in Q2 2024 and has held it in 7 quarters since.
  • Sanctuary Advisors's Utah Medical Products position peaked at $426K in Q4 2024.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.